Intraoperative monitoring of motor evoked potentials (MEPs) to transcranial stimulation of the motor cortex provides a method for monitoring the functional integrity of descending motor pathways during invasive manipulation of the spine or thoracoabdominal aortic replacement. 1±3 However, clinical and experimental use of these techniques has shown that the elicited responses are suppressed by most anaesthetic agents. 4±8 Nitrous oxide is frequently used during MEP monitoring as a supplemental anaesthetic. 2 3 6 7 A number of investigators have demonstrated that nitrous oxide suppresses MEPs in a dose-dependent manner in humans, as well as in animal studies.
9±15
Although recent advances in stimulation techniques using multipulse transcranial stimulation have been shown to overcome anaesthesia-induced suppression of MEPs, 16±21 the ef®cacy of this technique may be limited as the dose of anaesthetic increases.
Investigations in animals have shown that mild to moderate hypothermia is associated with a substantial decrease in histological damage in models of spinal cord ischaemia and injury. 22±24 Therefore, hypothermic therapy has been indicated during procedures such as thoracoabdominal aortic replacement, in which the spinal cord is susceptible to ischaemia and injury. MEP monitoring may therefore be required under hypothermic conditions during such procedures. 25±28 However, there have been few reports detailing the effects of hypothermia on MEPs. In particular, no data are available regarding the in¯uence of hypothermia on anaesthetic-induced suppression of MEPs. The present study was therefore conducted to investigate the effect of hypothermia on nitrous oxide-induced suppression of MEPs in rabbits.
Materials and methods
The study was approved by the Animal Experiment Committee of Nara Medical University. Twenty-two male New Zealand White rabbits weighing 2±3 kg were used in this study. They were housed and maintained on a 12 h light±dark cycle with free access to food and water.
Rabbits was given ketamine 50 mg kg ±1 i.m., and a 24-gauge catheter was inserted in the right ear vein. Thereafter, a continuous infusion of ketamine 17 mg kg ±1 h ±1 and fentanyl 33 kg ±1 h ±1 in lactated Ringer solution at a rate of 3 ml h ±1 was initiated. Another 24-gauge catheter was placed in the left ear vein for the administration of propofol. The trachea was intubated via a tracheostomy and the lungs were ventilated mechanically. The left femoral artery was exposed and cannulated for arterial pressure monitoring and blood gas analysis. Blood gases, pH, and haematocrit were measured periodically with a blood gas analyser (GEM premier, Mallinckrodt, Ann Arbor, MI, USA). Oesophageal temperature and right soleus muscle temperature were monitored continuously with a thermometer (Mon-a-Therm, Mallinckrodt, St Louis, MO, USA).
The rabbit was turned prone and the head was ®xed in a stereotactic frame. The scalp was re¯ected laterally and the calvaria exposed. Two small craniotomies were performed with an air drill. A point 0.5 mm lateral to the sagittal suture and 14.5 mm rostral from the lambdoid suture on the right hemisphere was chosen as the anodal stimulating site. 15 A point 0.5 mm to the right sagittal suture at the level of lambdoid suture was used for the cathode. Silver ball electrodes (1 mm in diameter) were placed epidurally via the holes, into which mineral oil was applied. Two standard recording needle electrodes were inserted a distance of 2 cm into the left soleus muscle. A ground electrode was set at the tail. Constant-voltage anodal stimulation was delivered through an electrical stimulator (SEN-3301, Nihon Kohden, Tokyo, Japan). The strength of the electrical stimulus was gradually increased until the MEP amplitude no longer increased. The recording device (Neuropack sigma, Nihon Kohden, Tokyo, Japan) was triggered by the stimulating device. Low-cutoff and high-cutoff ®lters were set at 30 Hz and 3 kHz, respectively. Train-of-®ve pulse stimulation was applied. The duration of each pulse was 200 ms and the interpulse interval was set at 2 ms.
When preparation was complete, animals were randomly allocated to one of three groups according to oesophageal temperature: the oesophageal temperature was maintained at 40°C in group 1 (n=8), at 35°C in group 2 (n=7), and at 30°C in group 3 (n=7). Cooling was achieved by wrapping the animal in a water blanket. In all groups, a bolus of propofol 10 mg kg ±1 was administered followed by a continuous infusion at 0.8 mg kg ±1 min ±1 . Thirty min after the bolus injection of propofol, control MEPs in response to train-of-®ve pulses were recorded. Peak-to-peak amplitude was determined from the average of three individual responses, and the amplitudes were converted to percentages of the control MEP amplitude (%MEP amplitude). The interval between each stimulation was set at 30±60 s. When control MEPs had been recorded, nitrous oxide was administered at concentrations of 30%, 50% and 70%. The order was randomized to eliminate time-course bias. At least 10 min was allowed to elapse between each target concentration, and the end-tidal concentration of nitrous oxide was con®rmed by a gas analyser. MEPs were recorded at each concentration of nitrous oxide. When recordings at the three different concentrations of nitrous oxide had been made, administration of nitrous oxide was discontinued. Following con®rmation that the end-tidal concentration of nitrous oxide was 0%, MEPs were recorded again. During the experimental periods, a bolus administration of phenylephrine was used if arterial pressure decreased by more than 20% of control. At the end of the experiment the animals were killed by an injection of potassium chloride, which caused cardiac arrest.
Statistical analysis
All values are expressed as mean (SD). Repeated-measures analysis of variance was used to compare physiological variables and amplitudes at each concentration of nitrous oxide within each group, followed by Fischer's protected least signi®cant difference test. Factorial analysis of variance was used to compare physiological variables and amplitudes between the groups, followed by Fischer's protected least signi®cant difference test. Results were considered signi®cant when P<0.05.
Results
Mean arterial pressure, heart rate, blood gases and haematocrit before administration of nitrous oxide are shown in Table 1 . There were no signi®cant differences in mean arterial pressure, pH, Pa O 2 , and Pa CO 2 between the three groups. Heart rate was signi®cantly lower at 35°C and Table 2 . There were no signi®cant differences in MEP amplitudes among the three groups. During the administration of nitrous oxide, MEPs could be recorded in all animals at 40°C. At 35°C and 30°C, MEPs were not observed during the administration of 70% nitrous oxide in one animal in each group. However, after discontinuation of nitrous oxide, MEPs were again observed in all animals.
Mean change in %MEP amplitude before and during the administration of nitrous oxide is shown in Figure 1 . Representative MEP responses before and during the administration of nitrous oxide in the three groups are shown in Figure 2 . Nitrous oxide reduced %MEP amplitude in a dose-dependent manner in all three groups. At 35°C and 30°C, %MEP amplitude during the administration of 30%, 50% and 70% nitrous oxide was signi®cantly lower than control values (P<0.05). At 40°C, %MEP amplitude during the administration of 70% nitrous oxide was signi®cantly lower than control values (P<0.05). The %MEP amplitude during the administration of 70% nitrous oxide was signi®cantly lower at 35°C than at 40°C (P<0.05). The %MEP amplitude during the administration of 50% and 70% nitrous oxide were signi®cantly lower at 30°C than at 40°C (P<0.05). However, when nitrous oxide was discontinued, no difference in %MEP amplitude was observed between the three groups.
Discussion
The results show that nitrous oxide suppressed MEPs in a dose-dependent manner in normothermic rabbits anaesthetized with ketamine, fentanyl and propofol. A reduction of core temperature to 35°C or 30°C did not signi®cantly affect the MEP amplitude before administration of nitrous oxide. However, MEP amplitude during the administration of nitrous oxide were signi®cantly lower during hypothermia (35°C and 30°C) than during normothermia. These results suggest that nitrous oxide-induced suppression of MEPs may be augumented during hypothermia.
Nitrous oxide has been shown to be a potent suppressor of MEPs in response to transcranial electrical and magnetic stimulation in humans and experimental animal models.
9±15
Zentner and colleagues 12 investigated the effects of 10±70% nitrous oxide on MEPs in response to electrical stimulation of the motor cortex in rabbits. They demonstrated a major suppressive effect of high nitrous oxide doses on MEP amplitudes. With 50% nitrous oxide, MEP amplitudes were suppressed to 14% of baseline values. The results of our previous study also showed that nitrous oxide signi®cantly reduced the amplitudes of MEPs in response to single-pulse and multi-pulse stimulation in a dose-dependent manner in rabbits anaesthetized with ketamine, fentanyl and propofol. 15 These ®ndings are compatible with the results obtained in the present study.
There have been few reports detailing the effect of hypothermia on MEPs. 29 30 Oro and Haghighi 29 investigated the effects of systemic hypothermia on spinal neurogenic MEPs recorded from the epidural space at L1±2 in rats anaesthetized with pentobarbital. They demonstrated that amplitudes of spinal MEPs in response to a Table 2 Amplitudes of motor evoked potentials before the administration of nitrous oxide. Data are expressed as mean (SD). There were no signi®cant differences between the groups.
40°C
3 5°C 3 0°C (n=8) (n=7) (n=7)
Amplitude ( single stimulation were signi®cantly reduced with a decrease in core temperature, and no spinal MEPs were detectable below 28°C. Meylaerts and colleagues 30 investigated the in¯uence of regional spinal cord hypothermia on myogenic MEPs in response to transcranial electrical stimulation with a train-of-®ve pulses in pigs anaesthetized with ketamine, sufentanil and nitrous oxide. Progressive cooling resulted in an increase in MEP amplitude at 28±30°C and was followed by a progressive decrease. In the present study, although control MEP amplitudes in the hypothermic groups tended to be higher than those in the normothermic group, these differences were not statistically signi®cant. However, con®gurational differences in the responses were evident at 40°C, 35°C, and 30°C. The in¯uence of hypothermia on MEPs requires further study.
To the best of our knowledge, this is the ®rst report of the effects of hypothermia on anaesthetic-induced suppression of MEPs. Data in the present study suggest that nitrous oxide-induced suppression of MEPs was greater during hypothermia than during normothermia. The mechanisms by which nitrous oxide-induced suppression of MEPs is augumented under hypothermia are unknown. One possible explanation is that sensitivity of myogenic MEPs to nitrous oxide might be increased during hypothermia. Antognini and colleagues 31 demonstrated that hypothermia decreased the minimum alveolar anaesthetic concentration (MAC) of nitrous oxide in rats. MAC of nitrous oxide was 1.9 atm during normothermia but was reduced to 1.6 atm at 30°C. It was suggested that this reduction in MAC was related to the effects of hypothermia on the solubility of nitrous oxide in the lipid membrane. Hypothermia-induced changes in synaptic transmission might have been responsible. During moderate hypothermia, MEP amplitudes may increase because longer duration of action potentials can increase the release of neurotransmitter in the synaptic space. 30 In fact, MEP amplitudes in the hypothermic groups, although not statistically signi®cant, tended to be higher than those in the normothermic group. This hypothermiainduced hyperresponsiveness might in¯uence the nitrous oxide-induced suppression of MEPs. Another possibility is that hypothermia-induced changes in background anaesthetic concentration might in¯uence these results. Leslie and colleagues 32 demonstrated that a temperature reduction of 3°C increased blood propofol concentration by 30% during a constant rate infusion. The results in our previous study have shown that the dosage of propofol as a background anaesthetic can affect nitrous oxide-induced suppression of MEPs in response to multi-pulse stimulation. 15 These premises are, however, speculative. Further study would be required to clarify this mechanism.
In summary, the effects of hypothermia on nitrous oxideinduced suppression of MEPs to transcranial multi-pulse stimulation were investigated in rabbits anaesthetized with ketamine, fentanyl and propofol. A reduction of core temperature to 35°C or 30°C did not signi®cantly affect the MEP amplitudes. However, the suppressive ef®cacy of nitrous oxide on MEPs was greater during hypothermia (35 and 30°C) than during normothermia. These results suggest that MEP monitoring is feasible during 30°C hypothermia. Nitrous oxide should be used carefully as a supplemental anaesthetic during intraoperative MEP monitoring, because of its marked suppressive effects on MEPs during hypothermia.
